Demetrix is a biotechnology startup founded in 2017 and based in Berkeley, CA with additional offices in Raleigh, NC. The company's slogan "Harnessing nature’s chemistry through fermentation to supply rare, potent cannabinoids for health and wellness, produced efficiently and sustainably" epitomizes its mission. Demetrix specializes in utilizing fermentation technology to produce rare cannabinoids for the health and wellness sectors, focusing on identifying and researching compounds with the highest potential to enhance human health.
The company's approach closely mirrors natural chemistry, allowing for the efficient and cost-effective production of bioactives while maintaining minimal environmental impact. Notably, Demetrix secured a significant $50.00M Series A investment on 11 July 2019, with the backing of prominent investors including Horizons Ventures, Tuatara Capital, and the Berkeley Catalyst Fund. This injection of capital positions the company for further growth and innovation in the biotechnology space.
